Previous close | 225.99 |
Open | 225.50 |
Bid | 204.05 x 1300 |
Ask | 231.19 x 800 |
Day's range | 223.68 - 231.74 |
52-week range | 195.47 - 254.00 |
Volume | |
Avg. volume | 494,277 |
Market cap | 22.859B |
Beta (5Y monthly) | 0.81 |
PE ratio (TTM) | 40.66 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.08 (0.99%) |
Ex-dividend date | 11 Jun 2024 |
1y target est | N/A |
Total fiscal 2024 revenue increased 12% to $5.5 billionTotal fiscal 2024 U.S. GAAP earnings per diluted share of $3.81; adjusted earnings per diluted share increased to $8.83Targeted restructuring plan announced DUBLIN, IRELAND , May 08, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024. Total revenue for the fourth quarter of fiscal 2024 increased 10% to $1.5 billion compared with
DUBLIN, IRELAND, May 01, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on June 26, 2024, to shareholders of record at the close of business on June 12, 2024. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at www.steris-ir.com. STERIS is a leading global provider of products and servic
DUBLIN, IRELAND, April 24, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter and full year financial results at 9:00 a.m. ET on May 9, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing fin